Tuberculosis: Latency and Reactivation

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2001 Jun 13

PMID 11401954

Citations 173

Authors

J L Flynn

J Chan

Affiliations

Soon will be listed here.

Citing Articles

Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers.

Woo S, Park P, An T, Fatima M, Moon Y, Lee S Hum Vaccin Immunother. 2025; 21(1):2457187.

PMID: 39957237 PMC: 11834422. DOI: 10.1080/21645515.2025.2457187.

A brief overview of mathematical modeling of the within-host dynamics of Mycobacterium tuberculosis.

Chakraborty D, Batabyal S, Ganusov V Front Appl Math Stat. 2025; 10.

PMID: 39906541 PMC: 11793202. DOI: 10.3389/fams.2024.1355373.

Preliminary X-ray diffraction and ligand-binding analyses of the N-terminal domain of hypothetical protein Rv1421 from Mycobacterium tuberculosis H37Rv.

Park J, Cheon Y, Jeong Y, Lee K Acta Crystallogr F Struct Biol Commun. 2024; 80(Pt 7):135-141.

PMID: 38935514 PMC: 11229554. DOI: 10.1107/S2053230X24005831.

Host Cell Death and Modulation of Immune Response against Infection.

Vu A, Glassman I, Campbell G, Yeganyan S, Nguyen J, Shin A Int J Mol Sci. 2024; 25(11).

PMID: 38892443 PMC: 11172987. DOI: 10.3390/ijms25116255.

Toward mechanistic medical digital twins: some use cases in immunology.

Laubenbacher R, Adler F, An G, Castiglione F, Eubank S, Fonseca L Front Digit Health. 2024; 6:1349595.

PMID: 38515550 PMC: 10955144. DOI: 10.3389/fdgth.2024.1349595.

References

Maini R, St Clair E, Breedveld F, Furst D, Kalden J, Weisman M . Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet. 2000; 354(9194):1932-9. DOI: 10.1016/s0140-6736(99)05246-0. View

Wayne L . Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am Rev Respir Dis. 1976; 114(4):807-11. DOI: 10.1164/arrd.1976.114.4.807. View

Orme I . A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis. 1988; 137(3):716-8. DOI: 10.1164/ajrccm/137.3.716. View

MacMicking J, NORTH R, LaCourse R, Mudgett J, Shah S, Nathan C . Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A. 1997; 94(10):5243-8. PMC: 24663. DOI: 10.1073/pnas.94.10.5243. View

Graham J . Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci U S A. 1999; 96(20):11554-9. PMC: 18072. DOI: 10.1073/pnas.96.20.11554. View

Hirsch C, Ellner J, Blinkhorn R, Toossi Z . In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci U S A. 1997; 94(8):3926-31. PMC: 20544. DOI: 10.1073/pnas.94.8.3926. View

Bonecini-Almeida M, Chitale S, Boutsikakis I, Geng J, Doo H, He S . Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. J Immunol. 1998; 160(9):4490-9. View

Dalton D, Keshav S, Figari I, Bradley A, Stewart T . Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993; 259(5102):1739-42. DOI: 10.1126/science.8456300. View

Flynn J, GOLDSTEIN M, Chan J, Triebold K, Pfeffer K, Lowenstein C . Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995; 2(6):561-72. DOI: 10.1016/1074-7613(95)90001-2. View

10.

MacMicking J, Nathan C, Hom G, Chartrain N, Fletcher D, Trumbauer M . Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995; 81(4):641-50. DOI: 10.1016/0092-8674(95)90085-3. View

11.

Wojciechowski W, DeSanctis J, Skamene E, Radzioch D . Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene. J Immunol. 1999; 163(5):2688-96. View

12.

Flynn J, Chan J . Immunology of tuberculosis. Annu Rev Immunol. 2001; 19:93-129. DOI: 10.1146/annurev.immunol.19.1.93. View

13.

Cole S, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D . Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998; 393(6685):537-44. DOI: 10.1038/31159. View

14.

Brooks J, Furney S, Orme I . Metronidazole therapy in mice infected with tuberculosis. Antimicrob Agents Chemother. 1999; 43(5):1285-8. PMC: 89261. DOI: 10.1128/AAC.43.5.1285. View

15.

Berthet F, Lagranderie M, Gounon P, Laurent-Winter C, Ensergueix D, Chavarot P . Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science. 1998; 282(5389):759-62. DOI: 10.1126/science.282.5389.759. View

16.

Bekker L, Moreira A, Bergtold A, Freeman S, Ryffel B, Kaplan G . Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun. 2000; 68(12):6954-61. PMC: 97804. DOI: 10.1128/IAI.68.12.6954-6961.2000. View

17.

McKinney J, Honer zu Bentrup K, Munoz-Elias E, Miczak A, Chen B, Chan W . Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature. 2000; 406(6797):735-8. DOI: 10.1038/35021074. View

18.

Hmama Z, Gabathuler R, Jefferies W, de Jong G, Reiner N . Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J Immunol. 1998; 161(9):4882-93. View

19.

Scanga C, Mohan V, Joseph H, Yu K, Chan J, Flynn J . Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun. 1999; 67(9):4531-8. PMC: 96774. DOI: 10.1128/IAI.67.9.4531-4538.1999. View

20.

Miyazaki E, Chaisson R, Bishai W . Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis. Antimicrob Agents Chemother. 1999; 43(9):2126-30. PMC: 89434. DOI: 10.1128/AAC.43.9.2126. View